ID   CHEV
AC   CVCL_ZU70
SY   CHEV.
DR   Wikidata; Q98125617
RX   PubMed=6289490;
RX   PubMed=6806672;
CC   Population: Caucasian; French.
CC   Virology: EBV-negative.
CC   Doubling time: 27-28 hours (PubMed=6289490).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
RX   PubMed=6289490; DOI=10.1111/j.1399-0039.1982.tb00328.x;
RA   Kalil J.E., Fellous M., Tanigaki N., Rosa F.M., Pagniez C., Herzog C.,
RA   Dastot H., Lenoir G.M.;
RT   "A new Epstein-Barr virus negative Burkitt's lymphoma derived
RT   cell-line. I. Analysis of cell surface markers and abnormal expression
RT   of HLA antigens.";
RL   Tissue Antigens 20:47-62(1982).
//
RX   PubMed=6806672; DOI=10.1038/298474a0;
RA   Lenoir G.M., Preud'homme J.-L., Bernheim A., Berger R.;
RT   "Correlation between immunoglobulin light chain expression and variant
RT   translocation in Burkitt's lymphoma.";
RL   Nature 298:474-476(1982).
//